These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5127090)

  • 1. Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy.
    Ostrenga J; Steinmetz C; Poulsen B
    J Pharm Sci; 1971 Aug; 60(8):1175-9. PubMed ID: 5127090
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of vehicle composition. II. Prediction of optimal vehicle composition.
    Ostrenga J; Steinmetz C; Poulsen B; Yett S
    J Pharm Sci; 1971 Aug; 60(8):1180-3. PubMed ID: 5127091
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles.
    Coldman MF; Poulsen BJ; Higuchi T
    J Pharm Sci; 1969 Sep; 58(9):1098-102. PubMed ID: 5346073
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of particle size and vehicle on the percutaneous absorption of fluocinolone acetonide.
    Barrett CW; Hadgraft JW; Caron GA; Sarkany I
    Br J Dermatol; 1965 Nov; 77(11):576-8. PubMed ID: 5853251
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and evaluation of ointment and cream vehicles for a new topical steroid, fluclorolone acetonide.
    Malone T; Haleblian JK; Poulsen BJ; Burdick KH
    Br J Dermatol; 1974 Feb; 90(2):187-95. PubMed ID: 4819137
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of topical vehicle composition on the in vitro release of fluocinolone acetonide and its acetate ester.
    Poulsen BJ; Young E; Coquilla V; Katz M
    J Pharm Sci; 1968 Jun; 57(6):928-33. PubMed ID: 5671339
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial properties of a propylene glycol based topical therapeutic agent.
    Olitzky I
    J Pharm Sci; 1965 May; 54(5):787-8. PubMed ID: 5845896
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluocinonide in FAPG base: a review of its therapeutic efficacy in inflammatory dermatoses.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1974; 7(5):337-43. PubMed ID: 4604483
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluocinonide--a new topical corticosteroid. Clinical evaluation.
    Mendelson CG
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):63-5. PubMed ID: 5291635
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug and vehicle deposition from topical applications: use of in vitro mass balance technique with minoxidil solutions.
    Tsai JC; Cappel MJ; Flynn GL; Weiner ND; Kreuter J; Ferry JJ
    J Pharm Sci; 1992 Aug; 81(8):736-43. PubMed ID: 1403715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of polyoxypropylene 15 stearyl ether and propylene glycol on percutaneous penetration rate of diflorasone diacetate.
    Turi JS; Danielson D; Woltersom JW
    J Pharm Sci; 1979 Mar; 68(3):275-80. PubMed ID: 423113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of penetration enhancement of lidocaine by nonionic surfactants through hairless mouse skin in vitro.
    Sarpotdar PP; Zatz JL
    J Pharm Sci; 1986 Feb; 75(2):176-81. PubMed ID: 3958929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of solubility parameters of drug and vehicle to predict flux through skin.
    Sloan KB; Koch SA; Siver KG; Flowers FP
    J Invest Dermatol; 1986 Aug; 87(2):244-52. PubMed ID: 3734472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Further observations with fluocinolone acetonide in local administration].
    Gatti JC; Cardama JE; Avila JJ; Carnevale Benino de Gar
    Prensa Med Argent; 1966 Sep; 53(35):1919-20. PubMed ID: 6011708
    [No Abstract]   [Full Text] [Related]  

  • 15. Transdermal delivery of buprenorphine through cadaver skin.
    Roy SD; Roos E; Sharma K
    J Pharm Sci; 1994 Feb; 83(2):126-30. PubMed ID: 8169777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propylene glycol as a vehicle for percutaneous absorption of therapeutic agents.
    Bailey DN
    J Anal Toxicol; 1992; 16(2):97-8. PubMed ID: 1380108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of formulation on the clinical response to topical fluocinolone acetonide.
    Portnoy B
    Br J Dermatol; 1965 Nov; 77(11):579-81. PubMed ID: 5853252
    [No Abstract]   [Full Text] [Related]  

  • 18. Vehicle effects on in vitro percutaneous absorption through rat and human skin.
    Hilton J; Woollen BH; Scott RC; Auton TR; Trebilcock KL; Wilks MF
    Pharm Res; 1994 Oct; 11(10):1396-400. PubMed ID: 7855041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vehicle dielectric properties on rectal absorption of acetaminophen.
    Shangraw RF; Walkling WD
    J Pharm Sci; 1971 Apr; 60(4):600-2. PubMed ID: 5128372
    [No Abstract]   [Full Text] [Related]  

  • 20. SCALP DERMATOSES. TREATMENT WITH FLUOCINOLONE ACETONIDE IN PROPYLENE GLYCOL.
    LUBOWE II
    Skin (Los Angeles); 1964 Sep; 3():267-9. PubMed ID: 14202034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.